HNB
OPRX icon

Huntington National Bank’s OptimizeRx OPRX Stock Holding History

Huntington National Bank’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,325
Closed -$13.3K – 4197
2024
Q2 		$13.3K Buy
+1,325
New +$14.6K ﹤0.01% 1590

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Huntington National Bank's OPRX Position: Q3 2024 in Review

Huntington National Bank sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 1,325 shares — an estimated $13.3K sold.

Huntington National Bank first reported a position in OPRX in Q2 2024 and held it in 1 quarter. The position peaked at $13.3K in Q2 2024. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.

  • Huntington National Bank reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
  • Huntington National Bank sold 1,325 OptimizeRx shares in Q3 2024, an estimated $13.3K.
  • Huntington National Bank first reported a position in OptimizeRx in Q2 2024 and held it in 1 quarter.
  • Huntington National Bank's OptimizeRx position peaked at $13.3K in Q2 2024.
  • 85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.

Based on Huntington National Bank's 13F filing for Q3 2024, filed 6 Nov 2024.